Angiodynamics Inc Revenue Growth Rates (ANGO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Angiodynamics Inc   (NASDAQ: ANGO)
 

ANGO's Revenue Growth by Quarter and Year

Angiodynamics Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ANGO Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter May 86.61
3rd Quarter February 77.48
2nd Quarter November 78.78
1st Quarter August 74.86
FY 317.73

ANGOs Annual Revenue
Angiodynamics Inc 's Revenue in the fiscal year 2026 $ 320.17 millions
Angiodynamics Inc 's Revenue in the fiscal year 2025 $ 291.71 millions
Angiodynamics Inc 's Revenue in the fiscal year 2024 $ 303.70 millions
Angiodynamics Inc 's Revenue in the fiscal year 2023 $ 338.25 millions
Angiodynamics Inc 's Revenue in the fiscal year 2022 $ 316.22 millions




ANGO Revenue fourth quarter 2025 Y/Y Growth Comment
Angiodynamics Inc achieved in the fourth quarter 2025, above Company average Revenue improvement of 8.04% year on year, to $ 86.61 millions.

Looking into fourth quarter 2025 results within Medical Equipment & Supplies industry 113 other companies have achieved higher Revenue growth. While Angiodynamics Inc ' s Revenue increase of 8.04% ranks overall at the positon no. 2137 in the fourth quarter 2025.


ANGO Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter May 8.04 % 12.93 % -22.06 % 4.68 %
3rd Quarter February 7.82 % -4.01 % -7.25 % 9.11 %
2nd Quarter November 9.55 % -8.11 % -8.39 % 9.13 %
1st Quarter August 12.2 % -14.53 % -4.27 % 5.94 %
FY   9.32 % -3.81 % -10.8 % -

Financial Statements
Angiodynamics Inc 's fourth quarter 2025 Revenue $ 86.61 millions ANGO's Income Statement
Angiodynamics Inc 's fourth quarter 2024 Revenue $ 80.16 millions Quarterly ANGO's Income Statement


ANGO Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter May 11.78 % 11.55 % -5.18 % 12.84 %
3rd Quarter February -1.65 % -0.07 % -4.34 % -5.52 %
2nd Quarter November 5.24 % 7.78 % 0.26 % 4.77 %
1st Quarter August -6.61 % -6 % -14.29 % -6.28 %
FY (Year on Year)   9.32 % -3.81 % -10.8 % -


Back to ANGO Growth rate Comparisons >> Back to ANGO Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #114
Healthcare Sector #312
Overall #2137

Revenue Y/Y Growth Statistics
High Average Low
12.32 % -0.53 % -21 %
(Feb 28 2022)   (May 31 2020)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #114
Healthcare Sector #312
Overall #2137
Revenue Y/Y Growth Statistics
High Average Low
12.32 % -0.53 % -21 %
(Feb 28 2022)   (May 31 2020)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Angiodynamics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
44.58 % 1.34 % -21.06 %
(Aug 31 2012)  


ANGO's IV. Quarter Q/Q Revenue Comment
Angiodynamics Inc achieved in the IV. Quarter 2025 above company average sequential Revenue rise of 11.78%, to $ 86.61 millions, from $77.48 millions in the third quarter.
ANGO is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 29 other companies have achieved higher Revenue quarter on quarter growth. While Angiodynamics Inc 's Revenue growth quarter on quarter, overall rank is 732.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #30
Healthcare Sector #119
Overall #732
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #30
Healthcare Sector #119
Overall #732
Revenue Q/Q Growth Statistics
High Average Low
44.58 % 1.34 % -21.06 %
(Aug 31 2012)  


ANGO's IV. Quarter Q/Q Revenue Comment
Angiodynamics Inc achieved in the IV. Quarter 2025 above company average sequential Revenue rise of 11.78%, to $ 86.61 millions, from $77.48 millions in the third quarter.
ANGO is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 29 other companies have achieved higher Revenue quarter on quarter growth. While Angiodynamics Inc 's Revenue growth quarter on quarter, overall rank is 732.


Angiodynamics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(May 31 2026)		 12 Months Ending
(Feb 28 2026)		 12 Months Ending
(Nov 30 2025)		 12 Months Ending
(Aug 31 2025)		 12 Months Ending
(May 31 2025)
Cumulative Revenue 12 Months Ending $ 317.73 $ 311.28 $ 305.66 $ 298.78 $ 290.65
Y / Y Revenue Growth (TTM) 9.32 % 10.59 % 7.45 % 2.73 % -3.81 %
Year on Year Revenue Growth Overall Ranking # 2764 # 298 # 137 # 26 # 78
Seqeuential Revenue Change (TTM) 2.07 % 1.84 % 2.3 % 2.8 % 3.26 %
Seq. Revenue Growth (TTM) Overall Ranking # 2137 # 253 # 116 # 24 # 71


Cumulative Revenue growth Comment
Assuming the Angiodynamics Inc 's fiscal year would have ended in May 31 2026, Angiodynamics Inc would have reprted above average annual Revenue improvement of 9.32% year on year, of $ 318 millions.
This marks a slow-down of the companys growth trends and from the 10.59% rise in Feb 28 2026.

In the Healthcare sector 392 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 298 to 2764.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 393
Overall # 2764

Revenue TTM Y/Y Growth Statistics
High Average Low
12.32 %
 -0.53 %
-21 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 114
Sector # 312
S&P 500 # 2137
Cumulative Revenue growth Comment
Assuming the Angiodynamics Inc 's fiscal year would have ended in May 31 2026, Angiodynamics Inc would have reprted above average annual Revenue improvement of 9.32% year on year, of $ 318 millions.
This marks a slow-down of the companys growth trends and from the 10.59% rise in Feb 28 2026.

In the Healthcare sector 392 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 298 to 2764.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 393
Overall # 2764

Revenue TTM Y/Y Growth Statistics
High Average Low
12.32 %
-0.53 %
-21 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 114
Sector # 312
S&P 500 # 2137




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ANGO's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending May 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending May 31 2026
Angiodynamics Inc 8.05%$ 8.045 millions


About Angiodynamics Inc Revenue Growth Rates (ANGO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Angiodynamics Inc (CIK 1275187).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-048138
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Angiodynamics Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.